Article citationsMore>>

Solomon, A.W., Engels, D., Bailey, R.L., Blake, I.M., Brooker, S., Chen, J.X., Chen, J.H., Churcher, T.S., Drakeley, C.J., Edwards, T., Fenwick, A., French, M., Gabrielli, A.F., Grassly, N.C., Harding-Esch, E.M., Holland, M.J., Koukounari, A., Lammie, P.J., Leslie, J. and Peeling, R.W. (2012) A Diagnostics Platform for the Integrated Mapping, Monitoring, and Surveillance of Neglected Tropical Diseases: Rationale and Target Product Profiles. PLOS Neglected Tropical Diseases, 6, e1746.
https://doi.org/10.1371/journal.pntd.0001746

has been cited by the following article:

• TITLE: Expression and Evaluation of Wb-SXP-1 and Wb-123 Recombinant Antigens as Potential Diagnostic Biomarkers for Lymphatic Filariasis

  AUTHORS: Sharlene Kerubo Mageto, Rebecca Wanjiku Waihenya, Anne Wanjiru Mwangi, Peter Kipkemboi Rotich, Matthew Mutinda Munyao, Tonny Teya, Robinson Mugasiali Irekwa, Joanne Jepkemei Yego, Caroline Wangui Njoroge, Grace Ng’endo Kanyita, Nicole Sian Tanchu, Dawala Koromtili Oumar, Primrose Muthoni Ndungu, Samson Muuo Nzou

  KEYWORDS: Lymphatic Filariasis, Recombinant Antigens, Diagnosis

  JOURNAL NAME: American Journal of Molecular Biology, Vol.13 No.2, February 23, 2023

  ABSTRACT: Lymphatic filariasis (LF) remains a public health concern as it can cause permanent morbidity and disability to those infected. While the global elimination of LF in these endemic areas is ongoing through mass drug administration, there is the need to develop diagnostic tools that would be utilized to track the progress of total global eradication as well as perform surveillance for the recurrence of lymphatic filariasis transmission. Currently, approved LF diagnosis tools are faced with lack of specificity, low sensitivity, and periodicity dependence. Recombinant filarial antigen-based assays can address these drawbacks and offer practical instruments for LF diagnosis and surveillance. This present study, evaluated rWb-SXP-1 and rWb-123 antigens as potential diagnostic biomarker tools for Wuchereria banchrofti in human sera using microspheres-based multiplex serological assay. Based on statistical analysis using XLSTAT 2019 (Addinsoft) on data generated from multiplex technology assay, generated ROC curves for both rWb-SXP-1 and rWb-123 demonstrated 87.1% sensitivity to Wuchereria banchrofti human sera with rWb-SXP-1 antigens having the highest specificity of 96%. Indication that rWb-SXP-1 and rWb-123 antigens are capable of detecting immunoglobulin G4 (IgG4) antibodies in human sera synthesized specifically against W. banchrofti infections. Therefore, rWb-SXP-1 and rWb-123 antigens can be utilized to detect W. banchrofti infections by antibody profiling with excellent diagnostic sensitivity and specificity using microsphere-based multiplex serological tests. This method can be particularly practical for screening a large number of sera samples and/or for quick, extensive field-testing due to the high-throughput and quick formats applied.